Latest stories on PHIO
Phio Pharmaceuticals to Present Clinical Development Update and Upcoming Catalysts at Life Sciences Future 2026 Conference
StockTitan56 · neutralproduct/pr
Phio Announces Key PH-762 Milestone with FDA Submission for Next Stage of Cutaneous Squamous Cell Carcinoma
Business Insider67 · bullishproduct/pr
Phio Pharmaceuticals Corp. (PHIO) files 8-K
SEC 8-K50 · neutralgeneral
Phio Pharmaceuticals to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
StockTitan56 · neutralproduct/pr
Phio Pharmaceuticals GAAP EPS of -$0.36 in-line
Seeking Alpha34 · bearishearnings
Phio Pharmaceuticals Corp. (PHIO) files 8-K
SEC 8-K50 · neutralgeneral
Phio Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update
StockTitan34 · bearishgeneral
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
StockTitan56 · neutralproduct/pr
Phio Pharmaceuticals adds dermatology expert to board
TipRanks56 · neutralgeneral
Phio Pharmaceuticals Corp. (PHIO) files 8-K
SEC 8-K50 · neutralgeneral
Phio Pharmaceuticals Announces Appointment of Dr. R. Todd Plott to the Board of Directors
StockTitan56 · neutralgeneral
Phio Pharmaceuticals Expands Global Patent Portfolio With New International Patent Milestones
InvestorsHub63 · neutralproduct/pr
Phio Pharmaceuticals Reaches Key Milestone in Advancing Lead Candidate PH-762 | PHIO Stock News
StockTitan67 · bullishproduct/pr
Phio Pharmaceuticals Announces Participation in the Life Sciences Investor Forum on June 24-25, 2026 | PHIO Stock News
StockTitan56 · neutralproduct/pr